Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape

Published by GlobalData Product code 979383
Published Content info 77 Pages
Delivery time: 1-2 business days
Price
Back to Top
Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape
Published: December 21, 2020 Content info: 77 Pages
Description

This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.

  • Findings are based on the industry's most comprehensive database of the Pharma industry (GlobalData's Pharma Intelligence Center). The 11 tables and 23 figures throughout the report illustrate major points and trends.

Reasons to Buy

  • What are the pipeline COVID-19 prophylactic vaccines by developer type?
  • What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?
  • What is the distribution of COVID-19 prophylactic vaccines clinical trials?
  • What and Where are CMOs vaccine manufacturing facilities?
  • What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?
  • What are the COVID-19 vaccine contract manufacturing service agreements by Service?
  • What are the COVID-19 vaccine contract manufacturing service agreements by CMO?
  • What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?
Table of Contents
Product Code: GDPS0034MAR

Table of Contents

Table of Contents

1 Executive Summary

2 Players

3 Technology Briefing

  • 3.1 What is COVID-19?
  • 3.2 COVID-19 Pipeline Vaccine Types and Technology

4 Trends

5 Industry Analysis

  • 5.1 COVID-19 Pipeline Vaccines
  • 5.2 COVID-19 Vaccine Projected Sales
  • 5.3 Contract Manufacturing Capabilities for Vaccines
  • 5.4 COVID-19 Vaccine Contract Service Agreements
  • 5.5 Investors in COVID-19 Vaccine Manufacturing
    • 5.5.1 Governments
    • 5.5.2 Pharma Companies
    • 5.5.3 CMOs

6 Value Chain

7 Companies

8 Appendix

  • 8.1 Methodology
  • 8.2 Bibliography
  • 8.3 Primary Research - Key Opinion Leaders
  • 8.4 Further Reading

9 About the Authors

List of Tables

List of Tables

  • Table 1: COVID-19 Vaccine Trends, 2020
  • Table 2: Highest Development (Phase II-Marketed) COVID-19 Vaccines, 2020
  • Table 3: Likelihood of Approval for Infectious Disease Vaccines, 2020
  • Table 4: Promising COVID-19 Vaccines with Fast Track, WARP, ESI and Rolling Submission Status 2020
  • Table 5: COVID-19 Vaccine Contract Manufacturing Service Agreements, 2020
  • Table 6: Government and Non-Governmental Organization Funding Announcements, 2020
  • Table 7: Pharma Funding Events, 2020
  • Table 8: CMO Funding Events, 2020
  • Table 9: CMOs with COVID-19 Vaccine Contract Service Agreements
  • Table 10: Pharma Company Sponsors with COVID-19 Vaccine Pipeline Drugs
  • Table 11: Further Reading

List of Figures

List of Figures

  • Figure 1: Leading Players for COVID-19 Vaccine Manufacturing and their Place on the Value Chain
  • Figure 2: COVID-19 Virus Life Cycle
  • Figure 3: Top COVID-19 Vaccine Trends, 2020
  • Figure 4: COVID-19 Pipeline Vaccines by Highest Phase, 2020
  • Fig
Back to Top